Exacerbations of COPD place enormous stress upon acute healthcare systems -they are one of the commonest causes of emergency hospital admission, and frequently result in readmission. Acute healthcare provision in England and Wales has adapted to deliver "frontdoor" efficiency, with the rise of acute physicians and an emphasis on seeing hospitalised patients quickly to improve safety and facilitate early discharge -an example of the popular healthcare improvement mantra that "every system is perfectly designed to get the results it gets". From this perspective, the results of the most recent national secondary care COPD audit are highly satisfying, demonstrating reduced inpatient mortality and length of stay (1).
However, there is substantial national variation in acute care (1) and readmission rates remain worryingly high, with more than 60% of patients readmitted to hospital at least once in the year following discharge (2) .
Outcomes from acute exacerbations of COPD are dependent on several factors beyond quality of care. These include the severity of the acute event, whether physiological derangements respond and improve to treatment during the admission (3), the baseline severity of respiratory disease in the individual, the influence of comorbidities and extrapulmonary manifestations such as sarcopenia and frailty (4-7)), as well as the individual's self-management skills and resilience (8) . This is illustrated by the work from Hodgson et al in this issue of Thorax, which demonstrates that the National Early Warning Score (and supposed respiratory patientspecific variations) that identify acute physiological derangements, have only modest discrimination in predicting in-patient mortality in COPD (9) . Measuring change in physiological derangements during an admission gives added information (3), whilst the composite DECAF score, which includes a baseline measure of respiratory disability (extended MRC dyspnoea score) as well as clinical indicators of the admission severity (e.g. consolidation and acidaemia), show much better discrimination for in-hospital mortality (10) .
It is difficult to entirely divorce what occurs during the acute inpatient stay with what occurs in the post-discharge period and beyond, and important to remember that even for a "revolving door" patient, much greater time is spent outside than inside the acute hospital setting. Furthermore, from the patient perspective, a hospitalisation is a devastating lifeevent with significant physical and psychosocial ramifications (11) that persist beyond the typical hospital stay following an acute exacerbation of COPD. To standardise and potentially improve the delivery of post-discharge care in COPD, there is growing enthusiasm for the role of discharge bundles to provide a structured aide memoire of evidence-based practices (12, 13) that can be delivered for all patients with a condition, irrespective of ward, specialty, or profession delivering care. Typically, a bundle should contain three to five practices that when performed collectively and reliably, improve patient outcomes. However, as is often of the case with interventions developed from quality improvement initiatives, the accompanying evidence has largely arisen from uncontrolled before-after study designs with an inherent high risk of bias.
The systematic review from Ospina et al in this issue of Thorax (14) is therefore welcome in collating current available evidence for discharge bundles in COPD. The authors were able to perform meta-analyses using data from randomised controlled trials, which demonstrated that discharge bundles were associated with fewer readmissions, albeit with no impact on health related quality of life or mortality. These findings are perhaps not as optimistic as some would hope for, and certainly not as impressive as findings from trials and systematic reviews of post-hospitalisation pulmonary rehabilitation (15) (16) (17) (18) .
Ospina et al highlight several practical issues surrounding discharge bundles. Consensus is lacking as to the optimal number of components in a bundle, or which components are considered core and optional. There was significant heterogeneity in both the number and type of components, ranging from 2 to 12 components of 26 distinct interventions that were included within discharge bundles. Included studies often did not provide information on how the components of the bundle were generated or chosen. Some components would be considered good practice and common sense, e.g. assessing use of medications, but have not been rigorously tested in the post-discharge period. Remarkably, there was not a single common intervention across the discharge bundles described in the four randomised controlled trials included for meta-analysis for readmissions. This raises the issue of whether a "one size fits all" discharge bundle, appropriate for all patients and localities, can or even should be realised. A recent study in Thorax has shown that gait speed, a simple surrogate marker of frailty, measured on the day of hospital discharge showed excellent discrimination in predicting readmission in older patients with COPD (4). This demonstrates the large heterogeneity in readmission risk between individuals (3, 4) , and distinct cohorts of patients with complex needs that might require increased and more individualised input than can be offered through a discharge bundle.
The implementation of discharge bundles can also be challenging. A recent retrospective study identified 28 different barriers, many of which related to staff resources and engagement (19) . Patient-related factors, such as cognitive impairment or psychological distress, can also have a significant impact on implementation (11) . Even with broad staff and patient acceptance of a discharge bundle, there is little guarantee that the individual components can be actioned. 
